But clinical trial averages don't predict your personal outcome, and results from FDA-approved formulations in controlled trials don't certify identical performance from a compounded formulation
The theory is that supporting the body natural GLP-1 production while also using a pharmaceutical agonist could provide complementary benefits, particularly for gut health and microbiome diversity
*Nuance note: Ive been hearing a claim of one-third weight loss in six-months, but I think the one-quarter number better represents the available data
Tirzepatide commonly causes nausea, vomiting, diarrhea, and decreased appetite, particularly during initiation and dose escalation
The appetite-suppressing effects occur through complex interactions with the central nervous system, which has led researchers to hypothesise that these medications might influence other reward-driven behaviours, including alcohol consumption
In contrast, the mitogen-activated protein kinase pathway remains responsive to insulins vasoconstrictive actions via endothelin-1 (ET-1), a potent vasoconstrictor
